Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2 variant 2 pseudogene

Molecular classification: Other (Pseudogene)

Overview

The ubiquitin-conjugating enzyme E2 variant 2 pseudogene (ENSG00000270857, also known as LOC101929053) is a genomic DNA sequence considered a pseudogene—a non-coding relic of a former protein-coding gene that has lost its protein-coding ability through evolution[1]. Unlike active ubiquitin-conjugating E2 enzymes, which play important roles in protein ubiquitination processes such as protein degradation, signaling, and cellular homeostasis[2], this pseudogene does not produce a functional protein and has no established biological or therapeutic relevance.

Other names: LOC101929053ENSG00000270857

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2 variant 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 variant 2 pseudogene.

Explore the full profile